Efficacy of First- & Second-Line Treatment in an In Vivo Model of Poorly Differentiated Neuroendocrine Carcinoma of the Pancreas. (2022) - Alva-Ruiz, R.; Abdelrahman, A.; Yonkus, J.; Watkins, R.; Tomlinson, J.; Graham, R.; Truty, M.